Wesley Reisin, Michael W. Rich, Douglas D. Schocken, Michael A
... opinion of ACCF and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, a ...
... opinion of ACCF and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, a ...
Obstacles to Ozone`s Use
... very important to include in any ozone treatment program. This is probably one of the biggest shortcomings among most physicians using ozone. They don't realize what a powerful tool it is and that it's going to leave a lot of trash in the blood that's been oxidized. I make the analogy that ozone is ...
... very important to include in any ozone treatment program. This is probably one of the biggest shortcomings among most physicians using ozone. They don't realize what a powerful tool it is and that it's going to leave a lot of trash in the blood that's been oxidized. I make the analogy that ozone is ...
Product Monograph
... Means of obtaining accurate determination of serum lithium levels should be available, since frequent serum determinations are required specially during the initial period of treatment. Lithium toxicity is closely related to serum lithium levels and during treatment they should usually not exceed 1. ...
... Means of obtaining accurate determination of serum lithium levels should be available, since frequent serum determinations are required specially during the initial period of treatment. Lithium toxicity is closely related to serum lithium levels and during treatment they should usually not exceed 1. ...
Diagnosis and Treatment of Headache
... This alert is based on the final results of the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study showing that children exposed to valproate products while their mothers were pregnant had decreased IQs at age 6 compared to children exposed to other anti-epileptic drugs. For additional d ...
... This alert is based on the final results of the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study showing that children exposed to valproate products while their mothers were pregnant had decreased IQs at age 6 compared to children exposed to other anti-epileptic drugs. For additional d ...
ACCF/AHA Expert Consensus Document ACCF/AHA 2011 Expert
... opinion of ACCF and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, a ...
... opinion of ACCF and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community. Topics chosen for coverage by expert consensus documents are so designed because the evidence base, the experience with technology, a ...
American College of Radiology ACR Appropriateness Criteria
... When both initial catheter angiography and noninvasive studies are negative in patients with nonperimesencephalic SAH, catheter angiography should still be repeated at 1–2 weeks. MRA has similar sensitivity but lower specificity than CTA for aneurysm detection. Useful in patients with renal failure ...
... When both initial catheter angiography and noninvasive studies are negative in patients with nonperimesencephalic SAH, catheter angiography should still be repeated at 1–2 weeks. MRA has similar sensitivity but lower specificity than CTA for aneurysm detection. Useful in patients with renal failure ...
ANTIBIOTIC TREATMENT FOR CYSTIC FIBROSIS Repor t of the UK Cystic
... for two weeks every three months to control chronic P.aeruginosa infection. This regimen resulted in a better five year survival.9 [2-] It is now suggested that only patients requiring this frequency of antibiotic administration to maintain clinical stability should be considered for such treatment. ...
... for two weeks every three months to control chronic P.aeruginosa infection. This regimen resulted in a better five year survival.9 [2-] It is now suggested that only patients requiring this frequency of antibiotic administration to maintain clinical stability should be considered for such treatment. ...
Mannitol dry powder for inhalation for treating cystic fibrosis
... The health states in the model include cystic fibrosis, cystic fibrosis with improved respiratory symptoms, lung transplantation, death from cystic fibrosis, and death from an unrelated cause. At baseline, all patients enter the cystic fibrosis health state. As patients progress, if their FEV1% pred ...
... The health states in the model include cystic fibrosis, cystic fibrosis with improved respiratory symptoms, lung transplantation, death from cystic fibrosis, and death from an unrelated cause. At baseline, all patients enter the cystic fibrosis health state. As patients progress, if their FEV1% pred ...
Pneumococcal Septic Arthritis: Review of 190 Cases
... of the hip prostheses, which were removed and reimplanted after long courses of intravenous antibiotics. One of these patients also had bilateral infection of knee prostheses, which were drained and left in place. She continued to receive oral suppressive antibiotics. The remaining 8 patients, who d ...
... of the hip prostheses, which were removed and reimplanted after long courses of intravenous antibiotics. One of these patients also had bilateral infection of knee prostheses, which were drained and left in place. She continued to receive oral suppressive antibiotics. The remaining 8 patients, who d ...
STNDARD TREATMENT GUIDELINE FOR PRIMARY HOSPITALS
... Three times a day World Health Organization ...
... Three times a day World Health Organization ...
as a PDF
... the strongest evidence. For depressive relapse prevention, valproate, lamotrigine and imipramine performed better than placebo, with evidence strongest for lamotrigine and weakest for imipramine. For manic relapses, lithium and olanzapine performed significantly better than placebo. The MTC found th ...
... the strongest evidence. For depressive relapse prevention, valproate, lamotrigine and imipramine performed better than placebo, with evidence strongest for lamotrigine and weakest for imipramine. For manic relapses, lithium and olanzapine performed significantly better than placebo. The MTC found th ...
Deferasirox for the treatment of iron overload associated with regular
... he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘ ...
... he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘ ...
Pharmacy E change®
... syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensu ...
... syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensu ...
Breo Ellipta
... Particular care is needed for patients who have been transferred from systemically active corticosteroids to inhaled corticosteroids because deaths due to adrenal insufficiency have occurred in patients with asthma during and after transfer from systemic corticosteroids to less systemically availabl ...
... Particular care is needed for patients who have been transferred from systemically active corticosteroids to inhaled corticosteroids because deaths due to adrenal insufficiency have occurred in patients with asthma during and after transfer from systemic corticosteroids to less systemically availabl ...
Anlage 2
... DESIGN: Double-blind, randomized placebo-controlled clinical trial. METHODS: Sixty-four HIV-positive patients were randomized to self-application of imiquimod cream or matched placebo into the anal canal three times a week for 4 months. Response was assessed by cytology, high-resolution anoscopy and ...
... DESIGN: Double-blind, randomized placebo-controlled clinical trial. METHODS: Sixty-four HIV-positive patients were randomized to self-application of imiquimod cream or matched placebo into the anal canal three times a week for 4 months. Response was assessed by cytology, high-resolution anoscopy and ...
Introduction P. Burney
... scientists and by governments. Although the cost-effectiveness of smoking cessation, pulmonary rehabilitation, and longterm oxygen therapy in the later stages of the disease are all high, there is little active treatment that can currently be offered. Recently, randomised controlled trials, specific ...
... scientists and by governments. Although the cost-effectiveness of smoking cessation, pulmonary rehabilitation, and longterm oxygen therapy in the later stages of the disease are all high, there is little active treatment that can currently be offered. Recently, randomised controlled trials, specific ...
VENTOLIN HFA Inhalation Aerosol prescribing
... supraventricular tachycardia), and hypersensitivity reactions (including urticaria, angioedema, rash) have been reported after the use of VENTOLIN HFA. In addition, albuterol, like other sympathomimetic agents, can cause adverse reactions such as hypokalemia, hypertension, peripheral vasodilatation, ...
... supraventricular tachycardia), and hypersensitivity reactions (including urticaria, angioedema, rash) have been reported after the use of VENTOLIN HFA. In addition, albuterol, like other sympathomimetic agents, can cause adverse reactions such as hypokalemia, hypertension, peripheral vasodilatation, ...
DYSPORT® (abobotulinumtoxinA) DOSING AND DILUTION GUIDE
... effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life ...
... effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life ...
Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective WAO P P
... large numbers of medical consultations worldwide. Its prevalence ranges between 0.3 and 11.3% depending on the study population (see Prevalence section), and in recent years, an increase in the rate of hospitalizations due to urticaria and angioedema has been observed in some countries.1 It has been ...
... large numbers of medical consultations worldwide. Its prevalence ranges between 0.3 and 11.3% depending on the study population (see Prevalence section), and in recent years, an increase in the rate of hospitalizations due to urticaria and angioedema has been observed in some countries.1 It has been ...
Diagnosis and Treatment of Urticaria and Angioedema
... large numbers of medical consultations worldwide. Its prevalence ranges between 0.3 and 11.3% depending on the study population (see Prevalence section), and in recent years, an increase in the rate of hospitalizations due to urticaria and angioedema has been observed in some countries.1 It has been ...
... large numbers of medical consultations worldwide. Its prevalence ranges between 0.3 and 11.3% depending on the study population (see Prevalence section), and in recent years, an increase in the rate of hospitalizations due to urticaria and angioedema has been observed in some countries.1 It has been ...
Update on allergy immunotherapy - Journal of Allergy and Clinical
... detailed information regarding the effects of AIT for the treatment of allergic respiratory disease. Both SLIT and SCIT have shown promising results in reducing topical corticosteroid use and improving SCORAD scores in patients with atopic dermatitis.37 SCIT has also been shown to be efficacious in ...
... detailed information regarding the effects of AIT for the treatment of allergic respiratory disease. Both SLIT and SCIT have shown promising results in reducing topical corticosteroid use and improving SCORAD scores in patients with atopic dermatitis.37 SCIT has also been shown to be efficacious in ...
International Consensus Report on Diagnosis and Treatment of
... coughing, wheezing, chest tightness, and difficult breathing that are usually reversible, but that can be severe and sometimes fatal. The major factors contributing to asthma morbidity and mortality are under-diagnosis and inappropriate treatment. Most exacerbations reflect a treatment failure becau ...
... coughing, wheezing, chest tightness, and difficult breathing that are usually reversible, but that can be severe and sometimes fatal. The major factors contributing to asthma morbidity and mortality are under-diagnosis and inappropriate treatment. Most exacerbations reflect a treatment failure becau ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.